Genmark Diagnostics RECEIVES FDA Clearance and 4 Stocks Reaching 52-Week Highs

Genmark Diagnostics (NASDAQ:GNMK) received 510(NYSE:K) clearance from the FDA for its eSensor Respiratory Virus Panel which is to be used on its XT-8 system. The test was designed to simultaneously detect and differentiate 14 clinically relevant viruses from patients suffering from an illness similar to Influenza. The shares closed at $8.20, up $0.3 or 3.8% on the day. They have traded in a 52-week range of $3.63 to $7.90.

Don’t Miss: Here’s the SECRET to Apple and Amazon’s Tablet Profits. 

Huntington Bancshare (NASDAQ:HBAN) is already adjusting origination criteria as a means to show the proposed rules and contingently planning a response to the final rules. These comments came from a presentation at Barclay Global Financial Services Conference. The shares closed at $6.95, up $0.14 or 2.06% on the day. They have traded in a 52-week range of $4.51 to $6.83.

Nordstrom (NYSE:JWN) is interested in entering Canada via a partnership with The Cadillac Fairview Corp, according to Women’s Wear Daily. Sources say that Nordstrom will covert a minimum of three Sears (NASDAQ:SHLD) sites. The shares closed at $57.95, up $0.18 or 0.31% on the day. They have traded in a 52-week range of $43.63 to $58.44.

Kar Auction Services (NYSE:KAR): KKR & Co. (NYSE:KKR), Apollo Global (NASDAQ:APO), and Clayton Dubilier & Rice have been considering buying out KAR Auction (NYSE:KAR) in a deal worth nearly $4 billion, according to Reuters, citing a number of people familiar with the issue. Currently, KAR remains in the beginning stages discussions regarding the buyout following the hire of Evercore Partners who will solicit offers, and there is no guarantee of a deal. The shares closed at $18.81, up $0.19 or 1.02% on the day. They have traded in a 52-week range of $10.92 to $18.75.

Caplease Funding Inc (NYSE:LSE) Board of Directors announced an rise of 8 percent in the company’s quarterly dividend which will start during Q3 of 2012 to 7c per share. The rise is a reflection of Caplease’s progress to date on its 2012 business plan, which includes new investments added or committed of  more than $100 million as well as portfolio management activity highlighted by the three Nestle properties’ leasing progress as well as the extension and lowering of the related mortgage debt for those properties. The Board of Directors intends to keep evaluating the company’s dividend policy for the rest of the year as it still begins its 2012 plan. Common and the preferred dividends for Q3 of 2012 will be payable on October 15 to stockholders of record as of September 28. The shares closed at $5.08, down $0.05 or 0.97% on the day. They have traded in a 52-week range of $3.06 to $5.14.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>